Jeremy S Minshull

Menlo Park, CA, United States of America

Jeremy S Minshull

USPTO Granted Patents = 123 

 

Average Co-Inventor Count = 4.3

ph-index = 51

Forward Citations = 8,243(Granted Patents)

Forward Citations (Not Self Cited) = 8,081(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • San Francisco, CA (US) (1998 - 2002)
  • Menlo Park, CA (US) (2001 - 2011)
  • Palo Alto, CA (US) (2013 - 2016)
  • Los Alston, CA (US) (2016 - 2017)
  • Los Altos, CA (US) (2004 - 2024)

Company Filing History:

goldMedal38 out of 124 
 
Maxygen, Inc.
 patents
silverMedal29 out of 33 
 
Dna Twopointo Inc.
 patents
bronzeMedal16 out of 17 
 
Verdia Inc.
 patents
413 out of 19 
 
Codexis Mayflower Holdings, LLC
 patents
513 out of 6,589 
 
Pioneer Hi-bred International, Inc.
 patents
610 out of 10 
 
Dna2.0, Inc.
 patents
76 out of 27 
 
E. I. Du Pont De Nemours
 patents
86 out of 16,338 
 
E.i. Dupont De Nemours and Company
 patents
94 out of 4,455 
 
Pfizer Corporation
 patents
103 out of 459 
 
Codexis, Inc.
 patents
113 out of 1,371 
 
Novozymes A/s
 patents
123 out of 20 
 
Pioneer Hi-bred Int'l Inc.
 patents
132 out of 125 
 
Butamax Advanced Biofuels LLC
 patents
142 out of 7 
 
Synthezyme, LLC
 patents
152 out of 31 
 
Calysta, Inc.
 patents
162 out of 47 
 
Pfizer Products Inc.
 patents
171 out of 1 
 
Codexis Mayflower Holding, LLC
 patent
181 out of 1 
 
Novozymas Als
 patent
191 out of 2,886 
 
The General Hospital Corporation
 patents
203 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Car-T Cell Modification
Eukaryotic Genome Modification
Artificial Micro-Rna
Gene Expression Vectors
Transposons And Transposases
Dna Cloning Systems
Biopolymer Engineering
Antibody Engineering
Synthetic Nucleic Acids
Functional Biomolecules
Fluorescent Proteins
Directed Evolution
123 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Jeremy S Minshull

Introduction:

Inventor Jeremy S Minshull, based in Menlo Park, CA (US), is a prolific innovator with an impressive portfolio of 117 patents, showcasing his expertise in genetic modification and gene expression in mammalian cells.

Latest Patents:

1. Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products: This patent presents groundbreaking methods and compositions for stable genetic modification of cultured mammalian cells for therapeutic or diagnostic applications.

2. DNA vectors and elements for sustained gene expression in eukaryotic cells: These polynucleotide vectors enable high expression of heterologous genes with novel elements that enhance gene expression, revolutionizing areas such as gene therapy and bioprocessing.

Career Highlights:

Jeremy S Minshull has made significant contributions to companies like Maxygen, Inc. and DNA Twopointo Inc., where his innovative work has led to advancements in genetic engineering and biotechnology. His expertise in gene transfer systems has opened new avenues in gene therapy and gene discovery.

Collaborations:

Throughout his career, Jeremy S Minshull has collaborated with experts in the field, including notable coworkers like Phillip A Patten and Jon Edward Ness. These collaborations have further enhanced his inventions and patents, strengthening his position as a leading inventor in the industry.

Conclusion:

Inventor Jeremy S Minshull's groundbreaking work in genetic modification and gene expression has paved the way for advancements in biotechnology and gene therapy. With a remarkable portfolio of patents and collaborations with industry experts, he continues to drive innovation in the field of genetic engineering.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…